-
-
-
C125379-100mgCabazitaxel (XRP6258) is a semi-synthetic derivative of a natural taxoid.
-
C125379-10mgCabazitaxel (XRP6258) is a semi-synthetic derivative of a natural taxoid.
-
C125379-250mgCabazitaxel (XRP6258) is a semi-synthetic derivative of a natural taxoid.
-
C125379-25mgCabazitaxel (XRP6258) is a semi-synthetic derivative of a natural taxoid.
-
C125379-500mgCabazitaxel (XRP6258) is a semi-synthetic derivative of a natural taxoid.
-
C125379-50mgCabazitaxel (XRP6258) is a semi-synthetic derivative of a natural taxoid.
-
C126195-100mgCabozantinib (XL184, BMS-907351) is a potent VEGFR2 inhibitor with IC50 of 0.035 nM and also inhibits c-Met, Ret, Kit, Flt-1/3/4, Tie2, and AXL with IC50 of 1.3 nM, 4 nM, 4.6 nM, 12 nM/11.3 nM/6 nM, 14.3 nM and 7 nM, respectively.A potent VEGFR2 and
-
C126195-10mgCabozantinib (XL184, BMS-907351) is a potent VEGFR2 inhibitor with IC50 of 0.035 nM and also inhibits c-Met, Ret, Kit, Flt-1/3/4, Tie2, and AXL with IC50 of 1.3 nM, 4 nM, 4.6 nM, 12 nM/11.3 nM/6 nM, 14.3 nM and 7 nM, respectively.A potent VEGFR2 and
-
C126195-250mgCabozantinib (XL184, BMS-907351) is a potent VEGFR2 inhibitor with IC50 of 0.035 nM and also inhibits c-Met, Ret, Kit, Flt-1/3/4, Tie2, and AXL with IC50 of 1.3 nM, 4 nM, 4.6 nM, 12 nM/11.3 nM/6 nM, 14.3 nM and 7 nM, respectively.A potent VEGFR2 and
-
C126195-50mgCabozantinib (XL184, BMS-907351) is a potent VEGFR2 inhibitor with IC50 of 0.035 nM and also inhibits c-Met, Ret, Kit, Flt-1/3/4, Tie2, and AXL with IC50 of 1.3 nM, 4 nM, 4.6 nM, 12 nM/11.3 nM/6 nM, 14.3 nM and 7 nM, respectively.A potent VEGFR2 and